These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 2565620)

  • 1. Complement activation in amyloid plaques in Alzheimer's dementia.
    Eikelenboom P; Hack CE; Rozemuller JM; Stam FC
    Virchows Arch B Cell Pathol Incl Mol Pathol; 1989; 56(4):259-62. PubMed ID: 2565620
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cytokines associated with amyloid plaques in Alzheimer's disease brain stimulate human glial and neuronal cell cultures to secrete early complement proteins, but not C1-inhibitor.
    Veerhuis R; Janssen I; De Groot CJ; Van Muiswinkel FL; Hack CE; Eikelenboom P
    Exp Neurol; 1999 Nov; 160(1):289-99. PubMed ID: 10630213
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immunoglobulins and complement factors in senile plaques. An immunoperoxidase study.
    Eikelenboom P; Stam FC
    Acta Neuropathol; 1982; 57(2-3):239-42. PubMed ID: 6812382
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Early complement components in Alzheimer's disease brains.
    Veerhuis R; Janssen I; Hack CE; Eikelenboom P
    Acta Neuropathol; 1996; 91(1):53-60. PubMed ID: 8773146
    [TBL] [Abstract][Full Text] [Related]  

  • 5. An immunohistochemical study on cerebral vascular and senile plaque amyloid in Alzheimer's dementia.
    Eikelenboom P; Stam FC
    Virchows Arch B Cell Pathol Incl Mol Pathol; 1984; 47(1):17-25. PubMed ID: 6151285
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immuno-electron-microscopic localization of complements in amyloid fibrils of senile plaques.
    Ishii T; Haga S
    Acta Neuropathol; 1984; 63(4):296-300. PubMed ID: 6382906
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Expression of complement system components during aging and amyloid deposition in APP transgenic mice.
    Reichwald J; Danner S; Wiederhold KH; Staufenbiel M
    J Neuroinflammation; 2009 Nov; 6():35. PubMed ID: 19917141
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Complement activation in very early Alzheimer disease.
    Zanjani H; Finch CE; Kemper C; Atkinson J; McKeel D; Morris JC; Price JL
    Alzheimer Dis Assoc Disord; 2005; 19(2):55-66. PubMed ID: 15942322
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibiting the formation of classical C3-convertase on the Alzheimer's beta-amyloid peptide.
    Emmerling MR; Spiegel K; Watson MD
    Immunopharmacology; 1997 Dec; 38(1-2):101-9. PubMed ID: 9476121
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Complement activation in chromosome 13 dementias. Similarities with Alzheimer's disease.
    Rostagno A; Revesz T; Lashley T; Tomidokoro Y; Magnotti L; Braendgaard H; Plant G; Bojsen-Møller M; Holton J; Frangione B; Ghiso J
    J Biol Chem; 2002 Dec; 277(51):49782-90. PubMed ID: 12388551
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Amyloid beta plaque-associated proteins C1q and SAP enhance the Abeta1-42 peptide-induced cytokine secretion by adult human microglia in vitro.
    Veerhuis R; Van Breemen MJ; Hoozemans JM; Morbin M; Ouladhadj J; Tagliavini F; Eikelenboom P
    Acta Neuropathol; 2003 Feb; 105(2):135-44. PubMed ID: 12536224
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cerebral amyloid plaques in Alzheimer's disease but not in scrapie-affected mice are closely associated with a local inflammatory process.
    Eikelenboom P; Rozemuller JM; Kraal G; Stam FC; McBride PA; Bruce ME; Fraser H
    Virchows Arch B Cell Pathol Incl Mol Pathol; 1991; 60(5):329-36. PubMed ID: 1685040
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Up-regulated production and activation of the complement system in Alzheimer's disease brain.
    Yasojima K; Schwab C; McGeer EG; McGeer PL
    Am J Pathol; 1999 Mar; 154(3):927-36. PubMed ID: 10079271
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Distribution of A beta-associated proteins in cerebrovascular amyloid of Alzheimer's disease.
    Verbeek MM; Otte-Höller I; Veerhuis R; Ruiter DJ; De Waal RM
    Acta Neuropathol; 1998 Dec; 96(6):628-36. PubMed ID: 9845293
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Activation of the classical complement pathway in brain tissue of Alzheimer patients.
    McGeer PL; Akiyama H; Itagaki S; McGeer EG
    Neurosci Lett; 1989 Dec; 107(1-3):341-6. PubMed ID: 2559373
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Localization and cell association of C1q in Alzheimer's disease brain.
    Afagh A; Cummings BJ; Cribbs DH; Cotman CW; Tenner AJ
    Exp Neurol; 1996 Mar; 138(1):22-32. PubMed ID: 8593893
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A4 protein in Alzheimer's disease: primary and secondary cellular events in extracellular amyloid deposition.
    Rozemuller JM; Eikelenboom P; Stam FC; Beyreuther K; Masters CL
    J Neuropathol Exp Neurol; 1989 Nov; 48(6):674-91. PubMed ID: 2677252
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Alzheimer's beta-amyloid peptides can activate the early components of complement classical pathway in a C1q-independent manner.
    Bergamaschini L; Canziani S; Bottasso B; Cugno M; Braidotti P; Agostoni A
    Clin Exp Immunol; 1999 Mar; 115(3):526-33. PubMed ID: 10193429
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Alzheimer's disease and senile brains: an immunofluorescence study.
    Licandro A; Ferla S; Tavolato B
    Riv Patol Nerv Ment; 1983; 104(2):75-87. PubMed ID: 6387867
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Advanced glycation end products in Alzheimer's disease and other neurodegenerative diseases.
    Sasaki N; Fukatsu R; Tsuzuki K; Hayashi Y; Yoshida T; Fujii N; Koike T; Wakayama I; Yanagihara R; Garruto R; Amano N; Makita Z
    Am J Pathol; 1998 Oct; 153(4):1149-55. PubMed ID: 9777946
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.